| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Phase II multicenter study of neoadjuvant biochemotherapy for patients with stage III malignant melanoma. | J Clin Oncol | 2006 | 1.03 |
| 2 | Phase II, randomized, controlled, double-blinded trial of weekly elesclomol plus paclitaxel versus paclitaxel alone for stage IV metastatic melanoma. | J Clin Oncol | 2009 | 0.97 |
| 3 | A phase II study of neoadjuvant biochemotherapy for stage III melanoma. | Cancer | 2002 | 0.94 |
| 4 | A phase II study of biochemotherapy for advanced melanoma incorporating temozolomide, decrescendo interleukin-2 and GM-CSF. | Cancer Invest | 2005 | 0.80 |
| 5 | Nutritional, functional, and emotional characteristics related to fatigue in patients during and after biochemotherapy. | Oncol Nurs Forum | 2005 | 0.76 |
| 6 | Ellis Fischel Cancer Center needs Missouri's support. | Mo Med | 2009 | 0.75 |
| 7 | Melanoma reporting in Missouri. | Mo Med | 2005 | 0.75 |
| 8 | Multilobular tumor of bone in the mandible of a dog. | J Vet Dent | 2010 | 0.75 |